FDA authorization

FDA Authorizes Abbott's First Dual Glucose-Ketone Monitor

The FDA has authorized Abbott's Libre Duo 10 Day, the world's first wearable to continuously monitor both glucose and ketone levels, revolutionizing DKA prevention for patients aged 2+.